Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
This report is a detailed and comprehensive analysis for global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
- Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
- Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
- Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Radioisotopes for Nuclear Medicine Diagnosis and Treatment
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Radioisotopes for Nuclear Medicine Diagnosis and Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Carbon-14
- Technetium-99m
- Iodine-131
- Iodine-125
- Others
Market segment by Application
- Nuclear Medicine Diagnosis
- Nuclear Medicine Treatment
- Others
Market segment by players, this report covers
- NRG
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- China National Nuclear Corporation (CNNC)
- IRE ELIT
- Nordion
- Polatom
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Radioisotopes for Nuclear Medicine Diagnosis and Treatment product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, with revenue, gross margin, and global market share of Radioisotopes for Nuclear Medicine Diagnosis and Treatment from 2021 to 2026.
- Chapter 3, the Radioisotopes for Nuclear Medicine Diagnosis and Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Radioisotopes for Nuclear Medicine Diagnosis and Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Radioisotopes for Nuclear Medicine Diagnosis and Treatment.
- Chapter 13, to describe Radioisotopes for Nuclear Medicine Diagnosis and Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Type
1.3.1 Overview: Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type in 2025
1.3.3 Carbon-14
1.3.4 Technetium-99m
1.3.5 Iodine-131
1.3.6 Iodine-125
1.3.7 Others
1.4 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market by Application
1.4.1 Overview: Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Nuclear Medicine Diagnosis
1.4.3 Nuclear Medicine Treatment
1.4.4 Others
1.5 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size & Forecast
1.6 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast by Region
1.6.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region, (2021-2032)
1.6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.4 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.6 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.1.4 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 NRG Recent Developments and Future Plans
2.2 NTP Radioisotopes
2.2.1 NTP Radioisotopes Details
2.2.2 NTP Radioisotopes Major Business
2.2.3 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.2.4 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 NTP Radioisotopes Recent Developments and Future Plans
2.3 JSC Isotope
2.3.1 JSC Isotope Details
2.3.2 JSC Isotope Major Business
2.3.3 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.3.4 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 JSC Isotope Recent Developments and Future Plans
2.4 ANSTO
2.4.1 ANSTO Details
2.4.2 ANSTO Major Business
2.4.3 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.4.4 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ANSTO Recent Developments and Future Plans
2.5 China National Nuclear Corporation (CNNC)
2.5.1 China National Nuclear Corporation (CNNC) Details
2.5.2 China National Nuclear Corporation (CNNC) Major Business
2.5.3 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.5.4 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
2.6 IRE ELIT
2.6.1 IRE ELIT Details
2.6.2 IRE ELIT Major Business
2.6.3 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.6.4 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 IRE ELIT Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.7.4 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Polatom
2.8.1 Polatom Details
2.8.2 Polatom Major Business
2.8.3 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.8.4 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Polatom Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Company Revenue
3.2.2 Top 3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
3.2.3 Top 6 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Overall Company Footprint Analysis
3.3.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Region Footprint
3.3.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Type Footprint
3.3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value and Market Share by Type (2021-2026)
4.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2026)
5.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
6.2 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2021-2032)
6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
6.3.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
6.3.2 United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
6.3.3 Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
6.3.4 Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
7.2 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
7.3 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
7.3.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
7.3.2 Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.3 France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.5 Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.6 Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region
8.3.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2021-2032)
8.3.2 China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.3 Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.4 South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.5 India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.7 Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
9.2 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
9.3 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
9.3.1 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
9.3.2 Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
9.3.3 Argentina Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
10.3.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
10.3.2 Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
10.3.4 UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
11.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
11.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industry Chain
12.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Upstream Analysis
12.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Midstream Analysis
12.4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Type
1.3.1 Overview: Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type in 2025
1.3.3 Carbon-14
1.3.4 Technetium-99m
1.3.5 Iodine-131
1.3.6 Iodine-125
1.3.7 Others
1.4 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market by Application
1.4.1 Overview: Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Nuclear Medicine Diagnosis
1.4.3 Nuclear Medicine Treatment
1.4.4 Others
1.5 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size & Forecast
1.6 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast by Region
1.6.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region, (2021-2032)
1.6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.4 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.6 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.1.4 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 NRG Recent Developments and Future Plans
2.2 NTP Radioisotopes
2.2.1 NTP Radioisotopes Details
2.2.2 NTP Radioisotopes Major Business
2.2.3 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.2.4 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 NTP Radioisotopes Recent Developments and Future Plans
2.3 JSC Isotope
2.3.1 JSC Isotope Details
2.3.2 JSC Isotope Major Business
2.3.3 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.3.4 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 JSC Isotope Recent Developments and Future Plans
2.4 ANSTO
2.4.1 ANSTO Details
2.4.2 ANSTO Major Business
2.4.3 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.4.4 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ANSTO Recent Developments and Future Plans
2.5 China National Nuclear Corporation (CNNC)
2.5.1 China National Nuclear Corporation (CNNC) Details
2.5.2 China National Nuclear Corporation (CNNC) Major Business
2.5.3 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.5.4 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
2.6 IRE ELIT
2.6.1 IRE ELIT Details
2.6.2 IRE ELIT Major Business
2.6.3 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.6.4 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 IRE ELIT Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.7.4 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Polatom
2.8.1 Polatom Details
2.8.2 Polatom Major Business
2.8.3 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
2.8.4 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Polatom Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Company Revenue
3.2.2 Top 3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
3.2.3 Top 6 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Overall Company Footprint Analysis
3.3.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Region Footprint
3.3.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Type Footprint
3.3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value and Market Share by Type (2021-2026)
4.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2026)
5.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
6.2 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2021-2032)
6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
6.3.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
6.3.2 United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
6.3.3 Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
6.3.4 Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
7.2 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
7.3 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
7.3.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
7.3.2 Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.3 France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.5 Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
7.3.6 Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region
8.3.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2021-2032)
8.3.2 China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.3 Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.4 South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.5 India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
8.3.7 Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
9.2 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
9.3 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
9.3.1 South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
9.3.2 Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
9.3.3 Argentina Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country
10.3.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2032)
10.3.2 Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
10.3.4 UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
11.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
11.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industry Chain
12.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Upstream Analysis
12.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Midstream Analysis
12.4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2027-2032) & (USD Million)
Table 5. NRG Company Information, Head Office, and Major Competitors
Table 6. NRG Major Business
Table 7. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 8. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. NRG Recent Developments and Future Plans
Table 10. NTP Radioisotopes Company Information, Head Office, and Major Competitors
Table 11. NTP Radioisotopes Major Business
Table 12. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 13. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. NTP Radioisotopes Recent Developments and Future Plans
Table 15. JSC Isotope Company Information, Head Office, and Major Competitors
Table 16. JSC Isotope Major Business
Table 17. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 18. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. ANSTO Company Information, Head Office, and Major Competitors
Table 20. ANSTO Major Business
Table 21. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 22. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. ANSTO Recent Developments and Future Plans
Table 24. China National Nuclear Corporation (CNNC) Company Information, Head Office, and Major Competitors
Table 25. China National Nuclear Corporation (CNNC) Major Business
Table 26. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 27. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
Table 29. IRE ELIT Company Information, Head Office, and Major Competitors
Table 30. IRE ELIT Major Business
Table 31. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 32. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. IRE ELIT Recent Developments and Future Plans
Table 34. Nordion Company Information, Head Office, and Major Competitors
Table 35. Nordion Major Business
Table 36. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 37. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Nordion Recent Developments and Future Plans
Table 39. Polatom Company Information, Head Office, and Major Competitors
Table 40. Polatom Major Business
Table 41. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 42. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Polatom Recent Developments and Future Plans
Table 44. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million) by Players (2021-2026)
Table 45. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Share by Players (2021-2026)
Table 46. Breakdown of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in Radioisotopes for Nuclear Medicine Diagnosis and Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 48. Head Office of Key Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players
Table 49. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Type Footprint
Table 50. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Application Footprint
Table 51. Radioisotopes for Nuclear Medicine Diagnosis and Treatment New Market Entrants and Barriers to Market Entry
Table 52. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (USD Million) by Type (2021-2026)
Table 54. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Share by Type (2021-2026)
Table 55. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Forecast by Type (2027-2032)
Table 56. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026)
Table 57. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Forecast by Application (2027-2032)
Table 58. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 59. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 60. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 61. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 62. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 63. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 64. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 65. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 66. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 67. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 68. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 69. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 70. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 72. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 74. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 77. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 78. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 79. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 80. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 81. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 87. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 88. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment Upstream (Raw Materials)
Table 89. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Typical Customers
Table 1. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2027-2032) & (USD Million)
Table 5. NRG Company Information, Head Office, and Major Competitors
Table 6. NRG Major Business
Table 7. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 8. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. NRG Recent Developments and Future Plans
Table 10. NTP Radioisotopes Company Information, Head Office, and Major Competitors
Table 11. NTP Radioisotopes Major Business
Table 12. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 13. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. NTP Radioisotopes Recent Developments and Future Plans
Table 15. JSC Isotope Company Information, Head Office, and Major Competitors
Table 16. JSC Isotope Major Business
Table 17. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 18. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. ANSTO Company Information, Head Office, and Major Competitors
Table 20. ANSTO Major Business
Table 21. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 22. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. ANSTO Recent Developments and Future Plans
Table 24. China National Nuclear Corporation (CNNC) Company Information, Head Office, and Major Competitors
Table 25. China National Nuclear Corporation (CNNC) Major Business
Table 26. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 27. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
Table 29. IRE ELIT Company Information, Head Office, and Major Competitors
Table 30. IRE ELIT Major Business
Table 31. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 32. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. IRE ELIT Recent Developments and Future Plans
Table 34. Nordion Company Information, Head Office, and Major Competitors
Table 35. Nordion Major Business
Table 36. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 37. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Nordion Recent Developments and Future Plans
Table 39. Polatom Company Information, Head Office, and Major Competitors
Table 40. Polatom Major Business
Table 41. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product and Solutions
Table 42. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Polatom Recent Developments and Future Plans
Table 44. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (USD Million) by Players (2021-2026)
Table 45. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Share by Players (2021-2026)
Table 46. Breakdown of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in Radioisotopes for Nuclear Medicine Diagnosis and Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 48. Head Office of Key Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players
Table 49. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Type Footprint
Table 50. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market: Company Product Application Footprint
Table 51. Radioisotopes for Nuclear Medicine Diagnosis and Treatment New Market Entrants and Barriers to Market Entry
Table 52. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (USD Million) by Type (2021-2026)
Table 54. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Share by Type (2021-2026)
Table 55. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Forecast by Type (2027-2032)
Table 56. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026)
Table 57. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Forecast by Application (2027-2032)
Table 58. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 59. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 60. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 61. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 62. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 63. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 64. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 65. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 66. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 67. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 68. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 69. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 70. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 72. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 74. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 77. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 78. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 79. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 80. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 81. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2021-2026) & (USD Million)
Table 87. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Country (2027-2032) & (USD Million)
Table 88. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment Upstream (Raw Materials)
Table 89. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Typical Customers
LIST OF FIGURES
Figure 1. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Picture
Figure 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type in 2025
Figure 4. Carbon-14
Figure 5. Technetium-99m
Figure 6. Iodine-131
Figure 7. Iodine-125
Figure 8. Others
Figure 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application in 2025
Figure 11. Nuclear Medicine Diagnosis Picture
Figure 12. Nuclear Medicine Treatment Picture
Figure 13. Others Picture
Figure 14. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Region in 2025
Figure 19. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Share by Players in 2025
Figure 26. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Player Revenue in 2025
Figure 28. Top 3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
Figure 29. Top 6 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
Figure 30. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Share by Type (2021-2026)
Figure 31. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share Forecast by Type (2027-2032)
Figure 32. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Share by Application (2021-2026)
Figure 33. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share Forecast by Application (2027-2032)
Figure 34. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 44. France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Region (2021-2032)
Figure 51. China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 54. India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 68. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
Figure 69. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
Figure 70. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Picture
Figure 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type in 2025
Figure 4. Carbon-14
Figure 5. Technetium-99m
Figure 6. Iodine-131
Figure 7. Iodine-125
Figure 8. Others
Figure 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application in 2025
Figure 11. Nuclear Medicine Diagnosis Picture
Figure 12. Nuclear Medicine Treatment Picture
Figure 13. Others Picture
Figure 14. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Region in 2025
Figure 19. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Share by Players in 2025
Figure 26. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Radioisotopes for Nuclear Medicine Diagnosis and Treatment by Player Revenue in 2025
Figure 28. Top 3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
Figure 29. Top 6 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players Market Share in 2025
Figure 30. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Share by Type (2021-2026)
Figure 31. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share Forecast by Type (2027-2032)
Figure 32. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Share by Application (2021-2026)
Figure 33. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share Forecast by Application (2027-2032)
Figure 34. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 44. France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Region (2021-2032)
Figure 51. China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 54. India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Consumption Value (2021-2032) & (USD Million)
Figure 68. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers
Figure 69. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints
Figure 70. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
